3.92
price down icon9.05%   -0.39
pre-market  Pre-mercato:  3.94   0.02   +0.51%
loading

Indaptus Therapeutics Inc Azioni (INDP) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
45.53%
4.5726
3.1421 4.1089 3.9432 4.1796
Operating Income/Loss
45.53%
-4.5726
-3.1421 -4.1089 -3.9432 -4.1796
Nonoperating Income/Loss
45.04%
0.0401
0.073 0.0936 0.1366 0.1769
Income/Loss From Continuing Operations Before Tax
47.68%
-4.5324
-3.069 -4.0153 -3.8067 -4.0003
Income/Loss From Continuing Operations After Tax
47.68%
-4.5324
-3.069 -4.0153 -3.8067 -4.0028
Net Income/Loss
47.68%
-4.5324
-3.069 -4.0153 -3.8067 -4.0028
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
48.28%
14.10
9.5104 8.5439 8.4424 -
Diluted Average Shares
48.28%
14.10
9.5104 8.5439 8.4424 -
Basic Earnings Per Share
0.00%
-0.32
-0.32 -0.47 -0.45 -0.47
Diluted Earnings Per Share
0.00%
-0.32
-0.32 -0.47 -0.45 -0.47
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.35
price down icon 5.74%
$83.80
price down icon 1.12%
$31.81
price down icon 0.13%
$102.06
price down icon 2.32%
$162.33
price down icon 1.26%
biotechnology ONC
$320.10
price down icon 4.68%
Capitalizzazione:     |  Volume (24 ore):